Improved efficacy with maintained tolerability in the treatment of primary hypertension. Comparison between the felodipine-metoprolol combination tablet and monotherapy with enalapril

Journal of Human Hypertension

Volumn 13, Issue 1, 1999, Pages 55-60

  Andersson, O K ^a  

^a Göteborg School of Medicine   (Sweden)

Author keywords

Combination therapy; Enalapril; Felodipine; Metoprolol; Primary hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; FELODIPINE PLUS METOPROLOL;

ABDOMINAL PAIN; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; FATIGUE; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; STANDING; SUPINE POSITION; VERTIGO;

EID: 0032917495     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000724     Document Type: Article

References (28)

1. Zanchetti A et al. The 1993 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Pressure 1993; 2: 86-100.
2. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 1993; 153: 154-183.
3. Ménard J. Critical assessment of combination therapy development. Blood Pressure 1993; 2 (Suppl 1): 5-9.
4. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413-2446.
5. Abrahamsson B, Edgar B, Lidman K, Wingstrand K. Design and pharmacokinetics of Logimax®, a new extended-release combination tablet of felodipine and metoprolol. Blood Pressure 1993; 2 (Suppl 1): 10-15.
6. Dahlöf B, Andersson OK. A felodipine-metoprolol extended-release tablet: its properties and clinical development. J Hum Hypertens 1995; 9 (Suppl 2): S43-S47.
7. Todd PA, Faulds D. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders. Drugs 1992; 44: 251-277.
8. Benfield P, Clissold SP, Brogden RN. Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension. Drugs 1988; 31: 376-429.
9. Eriksson M et al. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations. Blood Pressure 1993; 2 (Suppl 1): 16-21.
10. Dahlöf B, Hosie J. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group. Blood Pressure 1993; 2 (Suppl 1): 22-29.
11. Dahlöf B et al. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone. Blood Pressure 1993; 2 (Suppl 1): 37-45.
12. Hoffmann J. Comparison of a felodipine-metoprolol combination tablet vs. each component alone as antihypertensive therapy. The German Multicentre Study Group. Blood Pressure 1993; 2 (Suppl 1): 30-36.
13. Hosie J, Dahlöf B, Klein G. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups. Blood Pressure 1993; 2 (Suppl 1): 46-50.
14. Todd PA, Goa KL. Enalapril: a reappraisal of its pharmacology and therapeutic use in hypertension. Drugs 1992; 43: 346-381.
15. Waeber B, Brunner HR. Main objectives and new aspects of combination treatment of hypertension. J Hypertens 1995; 13 (Suppl 2): S15-S19.
16. Gordon RD et al. Effects of felodipine, metoprolol and their combination on BP at rest and during exercise and on volume regulatory hormones in hypertensive patients. Blood Pressure 1995; 4: 300-306.
17. Venables T et al. Low dose felodipine plus low dose metoprolol as once daily antihypertensive therapy. Am J Hypertens 1990; 3: 111A.
18. Wing LM et al. Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly. Blood Pressure 1994; 3: 82-89.
19. Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of coronary heart disease: the Framingham Study. Dis Chest 1969; 56: 43-52.
20. MacMahon S et al. Blood pressure, stroke, and coronary heart disease: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
21. Collins R et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in BP; overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
22. Dahlöf B et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
23. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97-104.
24. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
25. Wikstrand J et al Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY Study. JAMA 1988; 259: 1976-1982.
26. Isles CG et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986; 4: 141-156.
27. Samuelsson O et al. Cardiovascular morbidity in relation to change in BP and serum cholesterol levels in treated hypertension: results from the Primary Prevention Trial in Göteborg, Sweden. JAMA 1987; 258: 1768-1776.
28. Du XL et al. Case control study of stroke and the quality of hypertension control in north west England. BMJ 1997; 314: 272-276.